Abhishek Subramanian
Overview
Explore the profile of Abhishek Subramanian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
277
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Declercq M, Treps L, Geldhof V, Conchinha N, de Rooij L, Subramanian A, et al.
Liver Int
. 2024 Jun;
44(9):2382-2395.
PMID: 38847551
Background & Aims: Cystic fibrosis (CF) is considered a multisystemic disorder in which CF-associated liver disease (CFLD) is the third most common cause of mortality. Currently, no effective treatment is...
2.
Subramanian A, Zakeri P, Mousa M, Alnaqbi H, Alshamsi F, Bettoni L, et al.
Comput Struct Biotechnol J
. 2022 Oct;
20:5235-5255.
PMID: 36187917
Multi-omics technologies are being increasingly utilized in angiogenesis research. Yet, computational methods have not been widely used for angiogenic target discovery and prioritization in this field, partly because (wet-lab) vascular...
3.
de Rooij L, Becker L, Teuwen L, Boeckx B, Jansen S, Feys S, et al.
Cardiovasc Res
. 2022 Aug;
119(2):520-535.
PMID: 35998078
Aims: Severe acute respiratory syndrome coronavirus-2 infection causes COVID-19, which in severe cases evokes life-threatening acute respiratory distress syndrome (ARDS). Transcriptome signatures and the functional relevance of non-vascular cell types...
4.
Subramanian A, Becker L, Carmeliet P
Nat Metab
. 2021 May;
3(5):593-594.
PMID: 34031594
No abstract available.
5.
Taverna F, Goveia J, Karakach T, Khan S, Rohlenova K, Treps L, et al.
Nucleic Acids Res
. 2020 May;
48(W1):W385-W394.
PMID: 32392297
The amount of biological data, generated with (single cell) omics technologies, is rapidly increasing, thereby exacerbating bottlenecks in the data analysis and interpretation of omics experiments. Data mining platforms that...
6.
Rohlenova K, Goveia J, Garcia-Caballero M, Subramanian A, Kalucka J, Treps L, et al.
Cell Metab
. 2020 Apr;
31(4):862-877.e14.
PMID: 32268117
Endothelial cell (EC) metabolism is an emerging target for anti-angiogenic therapy in tumor angiogenesis and choroidal neovascularization (CNV), but little is known about individual EC metabolic transcriptomes. By single-cell RNA...
7.
Subramanian A, Sarkar R
Trends Parasitol
. 2018 Oct;
34(12):1068-1081.
PMID: 30318316
The hurdles in drug and vaccine development pipelines for leishmaniasis, a complex, multifaceted disease, are largely due to the digenetic lifecycle, differential clinical manifestations of the parasite, and the incomplete...
8.
Subramanian A, Sarkar R
J Mol Evol
. 2018 Jul;
86(7):443-456.
PMID: 30022295
The sandfly midgut and the human macrophage phagolysosome provide antagonistic metabolic niches for the endoparasite Leishmania to survive and populate. Although these environments fluctuate across developmental stages, the relative changes...
9.
Banerjee S, Subramanian A, Chattopadhyay J, Sarkar R
Mol Biosyst
. 2017 Oct;
13(12):2603-2614.
PMID: 29034927
Toxic cyanobacteria blooms populate water bodies by consuming external nutrients and releasing cyanotoxins that are detrimental for other aquatic species, producing a significant impact on the plankton ecosystem and food...
10.
Subramanian A, Sarkar R
Sci Rep
. 2017 Sep;
7(1):10262.
PMID: 28860532
Human macrophage phagolysosome and sandfly midgut provide antagonistic ecological niches for Leishmania parasites to survive and proliferate. Parasites optimize their metabolism to utilize the available inadequate resources by adapting to...